Project Grant HT94252310756
Award Date
8/15/23
Completion Date
8/14/26
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Syracuse, NY 13244, USA
Similar Awards
The Defense Health Agency awarded a $1,694,245 Project Grant to New York University (NYU) School of Medicine, a private non-profit research institution and medical school, to develop innovative therapeutics against pressure ulcer-associated bacteria. The 4-year grant, which runs from August 2023 to August 2027, is funded under the Military Medical Research and Development program (CFDA 12.420). Through this award, NYU School of Medicine will conduct research to identify and advance new...
This federal Project Grant award of $1,540,000.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports the development of a Multifunctional Medical Foam (MF) to enhance acute wound management in situ. The grant is awarded to Colorado State University (CSU) and will fund research over a 3-year period from March 2025 to February 2028. CSU, a comprehensive public land-grant research university, will leverage its expertise in areas such as...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $4,000,000.00 in funding to Medcura, Inc. in Riverdale, MD to expand the development and production of a biopolymer powder treatment for noncompressible torso hemorrhage. The research aims to improve health outcomes for military service members and the broader public by advancing this innovative medical technology. The award period extends from Aug 5,...
The Department of the Army Medical Command awarded a $3,246,800 project grant to Duke University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop resorbable poly(ester urea) films for sustained delivery of meloxicam and bupivacaine to manage pain in critical combat casualty environments. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
The U.S. Department of Defense's Defense Health Agency has awarded a $902,109 Project Grant to North Carolina State University (NC State) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," supports the development of advanced nanoparticle-based technologies to improve hemorrhage control at the point of injury. The award period runs from July 1, 2024 to...
This $1,199,997.00 Project Grant award from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), is funding research to prevent trauma-related infections during prolonged care. The grant was awarded on Sep 30, 2023 to The Trustees Of The University Of Pennsylvania - doing business as Clinical Practices Of The University Of Pennsylvania, a private university and non-profit research institution. The research aims to develop...
The U.S. Department of Defense (DoD) Defense Health Agency awarded a $1,820,004 Project Grant to Case Western Reserve University's Office of Research Administration Division, doing business as the University Hospitals of Cleveland, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," will support the development of an innovative nanoparticle-based technology...
The Defense Health Agency awarded The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, a $1,986,275 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of biofabricated, patient-specific skin gloves as a personalized therapy for mitten deformities in epidermolysis bullosa, a rare genetic skin disorder. The project will run from June 15, 2023 to June 14, 2027. The Military...
This federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the "DEVELOPMENT OF INNOVATIVE THERAPEUTICS AGAINST PRESSURE ULCER-ASSOCIATED BACTERIA" at New York University School of Medicine. The $1,695,467.00 award, active from August 15, 2023 to August 14, 2027, will fund research to develop innovative treatments against bacteria associated with pressure ulcers. As a private...
The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The...